Complex manufacturing processes are a main challenge for the GMP-compliant production of CAR T cells

CAR T cells are an innovative ATMP with high therapeutic potential for various indications. The complex manufacturing process under GMP conditions poses a particular challenge to further advance the clinical development. In this review article, decentralized academic production through automation technologies is discussed as an option to overcome this hurdle.

Read more

Do you also face the challenge of manufacturing your cellular products GMP-compliant for the clinical development? We will be happy to provide you with a fast and easy answer to your GMP-compliant ATMP manufacturing needs: Our concept is based on a production in flexible container-based clean room facilities supported by competent GMP-support, which includes obtaining a manufacturing authorization according to §13 AMG.

We look forward to accompanying you through this process and supporting you with our long-standing expertise in the field of ATMPs.

Find out also about our services on the subject of GMP for ATMPs